BridgeMD
New treatment option for Prostatic Neoplasm
Official title Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
ClinicalTrials.gov ID: NCT06046131
What this study is testing
- What it's testing
- The course and progression of prostate cancer is highly variable, depending on the individual characteristics, the aggressiveness of the disease at the time of diagnosis as well as the ethno-geographic origins of the individuals. The general objective of the project is to identify the clinical, genetic and environmental determinants (risk factors) of the evolution, progression and complications of the disease according to the treatment options.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Adult patients with incident case of prostate cancer Patient consulting the University Hospital of Guadeloupe or the University Hospital of Rennes...
You likely can't join if
- Physical or mental health judjed by the investigator as precluding participation in the research Protected adults (guardianship, curatorship...
The study team makes the final eligibility decision.
Where it's taking place
- Rennes, Ille-et-Vilaine, France
- Pointe-à-Pitre, Guadeloupe, Guadeloupe
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rennes, Ille-et-Vilaine, France; Pointe-à-Pitre, Guadeloupe, Guadeloupe. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.